Vietnam has seen great achievements in researching and producing vaccines, especially the production of 10 out of the 11 kinds mentioned in the nationwide expanded immunisation programme.
Hanoi (VNA) – Vietnam has seen great achievements 🌃in researching and producing vaccines, especially the production of 10 out of the 11 kinds mentioned in the nationwide expanded immunisation programme, said Deputy Health Minister Nguyen Thanh Long.
The country has taken the initiative in preventing dangerous infectious diseases over the past years, Long stated at a seminar themed “Vietnam’s vaccines – Development and Integration” in Hanoi on December 22.
Reports delivered at the event showed that expanded immunisation is one of the safest and most efficient measures to reduce fatalities and improve life quality.
Since being implemented nationwide in 1985, the programme has helped protect around 6.7 million children from five infectious diseases, namely newborn tetanus, measles, diphtheria, whooping cough and poliomyelitis and avoid 42,900 fatalities caused by these diseases.
In 2015, Vietnam’s National Regulatory Authority for vaccines was recognised to meet international requirements by the World Health Organisation. It means that Vietnam’s vaccines align with international standards and are acknowledged by the international community.
However, the country’s export of vaccines has yet to meet expectations, according to reports.
As such, the seminar was held by the Health Ministry to discuss Vietnam’s advantages and potential in researching and producing vaccines as well as sharing assessments of technologies in vaccine production serving domestic demands and export.-VNA
Tran Dac Phu, Director of the Preventive Medicine Department, speaks to Vietnam News Agency about the quality of vaccines under the national programme on immunisation.
Dengue fever vaccine tests in the past five years in Vietnam showed real promise, according to the Preventive Medicine Department under the Ministry of Health.
Around 49,000 doses of the 6-in-1 vaccine will be available in Vietnam in 2016, the Drug Administration of Vietnam (DAV) under the Ministry of Health said on November 12.
Vietnam has successfully produced a vaccine to combat the Porcilis Porcine Reproductive Respiratory Syndrome (PRRS), which is also known as “Blue Ear Pig Disease”.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Illustrative image (Source: VNA)
